Search

Your search keyword '"Pankratz, Mira"' showing total 3 results
Start Over Author "Pankratz, Mira"
3 results on '"Pankratz, Mira"'

1. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

Author

Thol, Felicitas, Gabdoulline, Razif, Liebich, Alessandro, Klement, Piroska, Schiller, Johannes, Kandziora, Christian, Hambach, Lothar, Stadler, Michael, Koenecke, Christian, Flintrop, Madita, Pankratz, Mira, Wichmann, Martin, Neziri, Blerina, Büttner, Konstantin, Heida, Bennet, Klesse, Sabrina, Chaturvedi, Anuhar, Kloos, Arnold, Göhring, Gudrun, Schlegelberger, Brigitte, Gaidzik, Verena I., Bullinger, Lars, Fiedler, Walter, Heim, Albert, Hamwi, Iyas, Eder, Matthias, Krauter, Jürgen, Schlenk, Richard F., Paschka, Peter, Döhner, Konstanze, Döhner, Hartmut, Ganser, Arnold, and Heuser, Michael

Published
2018
Full Text
View/download PDF

2. Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation

Author

Heuser, Michael, Gabdoulline, Razif, Löffeld, Patrick, Dobbernack, Vera, Kreimeyer, Henriette, Pankratz, Mira, Flintrop, Madita, Liebich, Alessandro, Klesse, Sabrina, Panagiota, Victoria, Stadler, Michael, Wichmann, Martin, Shahswar, Rabia, Platzbecker, Uwe, Thiede, Christian, Schroeder, Thomas, Kobbe, Guido, Geffers, Robert, Schlegelberger, Brigitte, Göhring, Gudrun, Kreipe, Hans-Heinrich, Germing, Ulrich, Ganser, Arnold, Kröger, Nicolaus, Koenecke, Christian, and Thol, Felicitas

Published
2017
Full Text
View/download PDF

3. Next-Generation Sequencing-Based Measurable Residual Disease (MRD) Monitoring Is Highly Predictive for Outcome after Allogeneic Stem Cell Transplantation

Author

Thol, Felicitas, Liebich, Alessandro, Gabdoulline, Razif, Klement, Piroska, Schiller, Johannes, Kandziora, Christian, Flintrop, Madita, Pankratz, Mira, Wichmann, Martin, Neziri, Blerina, Klesse, Sabrina, Chaturvedi, Anuhar, Kloos, Arnold, Gaidzik, Verena I., Paschka, Peter, Bullinger, Lars, Fiedler, Walter, Heim, Albert, Hambach, Lothar, Stadler, Michael, Hamwi, Iyas, Eder, Matthias, Krauter, Jürgen, Schlenk, Richard F., Dohner, Konstanze, Döhner, Hartmut, Ganser, Arnold, and Heuser, Michael

Abstract

Background:Molecular predictors for relapse following allogeneic haematopoietic stem cell transplantation (alloHSCT) are urgently needed as 30-40% of AML patients experience recurrence of disease after HSCT. Measurable residual disease monitoring (MRD) for nucleophosmin 1 (NPM1) mutations has proven to be highly predictive for relapse in AML patients treated with or without alloHSCT. However, the majority of AML patients undergoing alloHSCT do not have the favorable NPM1marker so that alternative markers and techniques are required. We studied a next-generation sequencing (NGS)-based error-corrected sequencing approach that is applicable to all mutations for its ability to prognosticate relapse and survival following alloHSCT.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results